Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies.

Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies.

<h4>Background</h4>Cervical cancer remains a primary reason for cancer malignancy among women worldwide, primarily due to human papillomavirus (HPV) strains HPV16 and HPV18. Despite having access to vaccines, there are few treatment options for advanced or recurring cases. This research...

Full description

Saved in:
Bibliographic Details
Main Authors: Hedieh Zargaran, Amir Ghaemi, Mohammad Shenagari, Mehdi Samadi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0312979
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items